Dr. Enrique Seoane-Vasquez, PhD

Enrique Seoane-Vazquez, PhD is professor in the area of pharmaceutical economic, regulation and policy at Chapman University School of Pharmacy. He holds a PhD in Social and Administrative Pharmacy from the University of Minnesota, and a BS in Economics from the University of Santiago. His previous work experience includes positions as Professor and Associate Professor at the School of Pharmacy-Boston, Massachusetts College of Pharmacy and Health Sciences (CPHS University). Assistant Professor at the  Ohio State University, College of Pharmacy and College of Public Health; and Research Fellow at the PRIME Institute, University of Minnesota, College of Pharmacy.

Recent research projects focus on prices of drugs in the US and other countries, intellectual property regulation of pharmaceuticals, and FDA policy and regulation. Dr. Seoane conducted more than 40 research projects for a variety of sponsors including the Agency for Healthcare Research and Quality, the Food and Drug Administration, the Kaiser Family Foundation, the Robert Wood Johnson Foundation, Ohio Medicaid, Ohio Public Employees Retirement System, the Inter-American Development Bank, the World Bank, and the World Health Organization. In 2004, he served as the pharmacy expert in the Ohio Commission to Reform Medicaid. Columbus of the Ohio Department of Job and Family Services. He also conducted research for governments, organizations, and associations of a dozen countries. Dr. Seoane published more than 60 articles and 125 abstracts in reference journals including the New England Journal of Medicine, the American Journal of CardiologyPLoS OneHealth Policy, and Value in Health. He has given more than 200 national and international presentations in his areas of expertise.

Dr. Seoane is the past-Chair of the Drug Policy and Pharmaceutical Services Committee of the American Public Health Association, and active member of the American Pharmacist Association, the Academy of Managed Care Pharmacy, the International Health Economists Association, and the International Society for Pharmacoeconomics and Outcomes Research.